Znanstveni rad - Izvorni znanstveni rad
Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers
Endocrine, 36 (2009), 1; 70-74. https://doi.org/10.1007/s12020-009-9186-y


Citirajte ovaj rad

Kaštelan, D., Dušek, T., Kraljević, I., Polašek, O., Giljević, Z., Solak, M. ... Koršić, M. (2009). Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers. Endocrine, 36. (1), 70-74. doi: 10.1007/s12020-009-9186-y

Kaštelan, Darko, et al. "Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers." Endocrine, vol. 36, br. 1, 2009, str. 70-74. https://doi.org/10.1007/s12020-009-9186-y

Kaštelan, Darko, Tina Dušek, Ivana Kraljević, Ozren Polašek, Zlatko Giljević, Mirsala Solak, Silva Zupančić Šalek, Jozo Jelčić, Izet Aganović i Mirko Koršić. "Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers." Endocrine 36, br. 1 (2009): 70-74. https://doi.org/10.1007/s12020-009-9186-y

Kaštelan, D., et al. (2009) 'Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers', Endocrine, 36(1), str. 70-74. doi: 10.1007/s12020-009-9186-y

Kaštelan D, Dušek T, Kraljević I, Polašek O, Giljević Z, Solak M, i sur.. Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers. Endocrine [Internet]. 08.2009. [pristupljeno 11.07.2024.];36(1):70-74. doi: 10.1007/s12020-009-9186-y

D. Kaštelan, et al., "Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers", Endocrine, vol. 36, br. 1, str. 70-74, Kolovoz 2009. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:887716. [Citirano: 11.07.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.